09/26/2014 - 2:25pm

Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease. 

09/26/2014 - 1:03pm

Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma. 

09/26/2014 - 12:10pm

Mars on Friday announced a number of leadership changes, which include the departure of Todd Lachman, current president of the company's global petcare division. 

09/26/2014 - 11:37am

Camber Pharmaceuticals announced the launch of raloxifene hydrochloride, USP tablets in 60-mg dosage strengths.

09/26/2014 - 11:26am

Coty announced on Friday that recording artist and actress Demi Lovato is joining N.Y.C. New York Color as its first-ever global brand ambassador.

09/26/2014 - 11:10am

Not Your Mother’s hair care is hitting Fred Meyer shelves this fall, the company has announced.

09/25/2014 - 2:01pm

Members of the Global Market Development Center attended more than 8,000 scheduled meetings in the span of five days at the 2014 General Merchandise Marketing Conference held in San Antonio from Sept. 5 to 9, GMDC has announced.

09/25/2014 - 1:31pm

Jones Soda Co. announced the launch of Jones Sparkling Water, which was created in response to consumer demand for healthier products.

 

09/25/2014 - 1:04pm

Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.